Disclosure Of Cash Flow Statement [Text Block]

Innate Pharma - Filing #2821023

Concept As at
2020-12-31
As at
2019-12-31
As at
2018-12-31
Disclosure of cash flow statement [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
136 792 EUR
202 887 EUR
152 314 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.